Position in CSBR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$122,607
-$84,658 QoQ
Shares Held
21,323
-28.9% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CSBR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ACADIAN ASSET MANAGEMENT LLC holds $658,704,928 across 179 Biotechnology names. CSBR ranks #136 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
1,900,824 | $178,905,554 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
151,191 | $116,816,214 | |
| 3 | LEGN |
Legend Biotech Corp
|
1,527,336 | $27,629,508 | |
| 4 | TBPH |
Theravance Biopharma, Inc.
|
1,276,576 | $20,718,828 | |
| 5 | RIGL |
Rigel Pharmaceuticals Inc
|
666,426 | $18,020,159 | |
| 6 | IMCR |
Immunocore Holdings plc
|
501,091 | $15,107,893 | |
| 7 | PRTA |
Prothena Corp Public Ltd Co
|
1,547,593 | $15,042,603 | |
| 8 | PBYI |
Puma Biotechnology, Inc.
|
2,041,759 | $13,046,840 |
All Filings in CSBR
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $122,607 | 21,323 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $207,265 | 29,995 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $234,459 | 36,182 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $266,661 | 36,182 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $342,955 | 39,511 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $263,073 | 30,697 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $149,494 | 30,697 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $158,703 | 30,697 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $150,415 | 30,697 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $172,517 | 30,697 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $190,628 | 30,697 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $195,846 | 30,697 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $126,533 | 31,476 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $141,956 | 31,476 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $236,070 | 31,476 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $251,808 | 31,476 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $255,899 | 31,476 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $263,139 | 31,476 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $321,369 | 31,476 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $323,583 | 31,477 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $355,690 | 31,477 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $295,937 | 27,427 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $233,877 | 25,284 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $195,807 | 20,482 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $135,405 | 18,298 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||